Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mauna Kea TechnologiesFRA:1MK -1.38%39 Gross Margin % is 74.34% as of Dec. 2025, which is 4% above its 10-year median of 71.38. GuruFocus rates FRA:1MK with a GF Score™ of 39/100 and a GF Value™ of €0.13. The stock has 6 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Mauna Kea Technologies ranks better than 86.48% on this metric.
FRA:1MK's Gross Margin % is ranked better than 86.48% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs FRA:1MK: 75.33
Mauna Kea Technologies had a gross margin of 74.34% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Mauna Kea Technologies was 3.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Mauna Kea Technologies had a gross margin of 74.34% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Mauna Kea Technologies Gross Margin % Related Terms
Mauna Kea Technologies Gross Margin % Historical Data
* Premium members only.
The historical data trend for Mauna Kea Technologies's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1MK vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Mauna Kea Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mauna Kea Technologies Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Mauna Kea Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Mauna Kea Technologies (FRA:1MK) has a Gross Margin % of 74.34% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Mauna Kea Technologies and its competitors. This is near median its historical median of 71.38. Over the past decade, Mauna Kea Technologies' Gross Margin % has ranged from 65.60 to 84.13. According to the industry distribution chart, Mauna Kea Technologies ranks #109 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 13.5%.
Is Mauna Kea Technologies' Gross Margin % too high?
Mauna Kea Technologies' current Gross Margin % of 74.34% is near median its 10-year median of 71.38. Over the past 10 years, this metric has ranged from a low of 65.60 to a high of 84.13. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Mauna Kea Technologies' value of 74.34% is 42.6% above this industry median. Based on the distribution chart, Mauna Kea Technologies ranks #109 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Mauna Kea Technologies has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Mauna Kea Technologies' Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Mauna Kea Technologies ranks #109 out of 806 companies for Gross Margin %. This places Mauna Kea Technologies in the top 14% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.12. Mauna Kea Technologies' value of 74.34% is 42.6% above this benchmark. Historically, Mauna Kea Technologies' own Gross Margin % has ranged from 65.60 to 84.13 over the past decade. While the company's 10-year median is 71.38 vs. the industry median of 52.12, Mauna Kea Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mauna Kea Technologies's current Gross Margin % of 74.34% is 42.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Mauna Kea Technologies and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mauna Kea Technologies's current Gross Margin % is 74.34%, which is near median its own 10-year median of 71.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mauna Kea Technologies stock overvalued right now?
Mauna Kea Technologies (FRA:1MK) has a current Gross Margin % of 74.34%. The stock's GF Value™ is €0.13, compared to a current price of €0.14 — trading 9.7% above its estimated fair value. The current Gross Margin % is 74.34%, which is near median its 10-year median of 71.38 and 42.6% above the Medical Devices & Instruments industry median of 52.12. Mauna Kea Technologies' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Mauna Kea Technologies (FRA:1MK), the current Gross Margin % is 74.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mauna Kea Technologies (FRA:1MK) Overvalued in 2026?
Based on GuruFocus' analysis, Mauna Kea Technologies stock appears to be overvalued.
The current stock price of €0.14 is trading 9.7% above its estimated GF Value™ of €0.13.
Key valuation signals for FRA:1MK:
Gross Margin %: 74.34% (near median its 10-year median of 71.38)
GF Value™: €0.13 vs. price of €0.14 (9.7% above fair value)
Industry Position: 42.6% above the Medical Devices & Instruments median (#109 of 806)
No single metric tells the full story. See the FRA:1MK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company's flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia, of which the majority of the revenue is generated from USA and Canada.
39GF Score
Get the complete analysis for FRA:1MK
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1MK has been successfully added to your 
